Mok, C. C. Towards new avenues in the management of lupus glomerulonephritis. Nat. Rev. Rheumatol. 12, 221–234 (2016).

Article  CAS  PubMed  Google Scholar 

Mok, C. C., Kwok, R. C. L. & Yip, P. S. F. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum. 65, 2154–2160 (2013).

Article  CAS  PubMed  Google Scholar 

Kandane-Rathnayake, R. et al. Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus. Lupus 28, 1669–1677 (2019).

Article  CAS  PubMed  Google Scholar 

Kharawala, S. et al. Health-related quality of life, fatigue and health utilities in lupus nephritis: a systematic literature review. Lupus https://doi.org/10.1177/09612033221100910 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Jolly, M. et al. Disease-specific quality of life in patients with lupus nephritis. Lupus 27, 257–264 (2018).

Article  CAS  PubMed  Google Scholar 

Mok, C. C. & Tang, S. S. K. Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. Am. J. Med. 117, 791–795 (2004).

Article  PubMed  Google Scholar 

Lewis, M. J. & Jawad, A. S. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology 56, i67–i77 (2017).

CAS  PubMed  Google Scholar 

Parikh, S. V., Almaani, S., Brodsky, S. & Rovin, B. H. Update on lupus nephritis: core curriculum 2020. Am. J. Kidney Dis. 76, 265–281 (2020).

Article  PubMed  Google Scholar 

Tanaka, Y., O’Neill, S., Li, M., Tsai, I.-C. & Yang, Y.-W. Systemic lupus erythematosus: targeted literature review of the epidemiology, current treatment, and disease burden in the Asia Pacific Region. Arthritis Care Res. 74, 187–198 (2022).

Article  CAS  Google Scholar 

Jakes, R. W. et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 64, 159–168 (2012).

Article  Google Scholar 

Sexton, D. J. et al. ESRD from lupus nephritis in the United States, 1995–2010. Clin. J. Am. Soc. Nephrol. 10, 251–259 (2015).

Article  PubMed  Google Scholar 

Gómez-Puerta, J. A. et al. Racial and ethnic differences in mortality and cardiovascular events among patients with end-stage renal disease due to lupus nephritis. Arthritis Care Res. 67, 1453–1462 (2015).

Article  Google Scholar 

Nee, R. et al. Survival disparity of African American versus Non-African American patients with ESRD due to SLE. Am. J. Kidney Dis. 66, 630–637 (2015).

Article  PubMed  Google Scholar 

Iwamoto, T. & Niewold, T. B. Genetics of human lupus nephritis. Clin. Immunol. 185, 32–39 (2017).

Article  CAS  PubMed  Google Scholar 

Freedman, B. I. et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 66, 390–396 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Portalatin, G. M., Gebreselassie, S. K. & Bobart, S. A. Lupus nephritis — an update on disparities affecting African Americans. J. Natl Med. Assoc. 114, S34–S42 (2022).

PubMed  Google Scholar 

Jordan, J., Thompson, N. J., Dunlop-Thomas, C., Lim, S. S. & Drenkard, C. Relationships among organ damage, social support, and depression in African American women with systemic lupus erythematosus. Lupus 28, 253–260 (2019).

Article  CAS  PubMed  Google Scholar 

Kumar, K. et al. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin. Rheumatology 47, 690–697 (2008).

Article  CAS  PubMed  Google Scholar 

Hoi, A. Asian lupus in a multi-ethnic society: what can be learnt? Int. J. Rheum. Dis. 18, 113–116 (2015).

Article  PubMed  Google Scholar 

Rodríguez-Almaraz, E. et al. Something new about prognostic factors for lupus nephritis? A systematic review. Lupus 30, 2256–2267 (2021).

Article  PubMed  Google Scholar 

Moroni, G. et al. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann. Rheum. Dis. 77, 1318–1325 (2018).

Article  CAS  PubMed  Google Scholar 

Jorge, A. et al. All-cause and cause-specific mortality trends of end-stage renal disease due to lupus nephritis from 1995 to 2014. Arthritis Rheumatol. 71, 403–410 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Tektonidou, M. G., Dasgupta, A. & Ward, M. M. Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 68, 1432–1441 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Anders, H.-J. et al. The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021. Nephrol. Dial. Transpl. https://doi.org/10.1093/ndt/gfab351 (2021).

Article  Google Scholar 

Fanouriakis, A. et al. 2019 update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann. Rheum. Dis. 79, 713–723 (2020).

Article  CAS  PubMed  Google Scholar 

Mok, C. C. et al. The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus. Lancet Rheumatol. 3, e517–e531 (2021).

Article  CAS  Google Scholar 

Rovin, B. H. et al. Executive summary of the KDIGO 2021 Guideline for the management of glomerular diseases. Kidney Int. 100, 753–779 (2021).

Article  PubMed  Google Scholar 

Hahn, B. H. et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 64, 797–808 (2012).

Article  Google Scholar 

Houssiau, F. A. et al. The 10-year follow-up data of the Euro-Lupus Nephritis trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann. Rheum. Dis. 69, 61–64 (2010).

Article  CAS  PubMed  Google Scholar 

Rathi, M. et al. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis. Kidney Int. 89, 235–242 (2016).

Article  CAS  PubMed  Google Scholar 

Hsu, C.-Y. et al. Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study. Rheumatology 56, 620–628 (2017).

PubMed  Google Scholar 

Mok, C. C., Lau, C. S. & Wong, R. W. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum. 41, 831–837 (1998).

Article  CAS  PubMed  Google Scholar 

Mok, C. C. Mycophenolate mofetil for lupus nephritis: an update. Expert. Rev. Clin. Immunol. 11, 1353–1364 (2015).

Article  CAS  PubMed  Google Scholar 

Mok, C. C. et al. Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis. Ann. Rheum. Dis. 79, 1070–1076 (2020).

Article  PubMed  Google Scholar 

Liu, Z. et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann. Intern. Med. 162, 18–26 (2015).

Article  PubMed  Google Scholar 

Mok, C. C. et al. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. Ann. Rheum. Dis. 75, 30–36 (2016).

Article  PubMed  Google Scholar 

Austin, H. A., Illei, G. G., Braun, M. J. & Balow, J. E. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J. Am. Soc. Nephrol. 20, 901–911 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merrill, J. T. et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 62, 222–233 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rovin, B. H. et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 64, 1215–1226 (2012).

Article  CAS  PubMed  Google Scholar 

Díaz-Lagares, C. et al. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts. Autoimmun. Rev. 11, 357–364 (2012).

Article  PubMed